Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9622)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2017 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abe M, Yoshida T, Akiba J, Ikezono Y, Wada F, Masuda A, Sakaue T, Tanaka T, Iwamoto H, Nakamura T, Sata M, Koga H, Yoshimura A, Torimura T. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury. World J Gastroenterol 2017; 23(37): 6833-6844 [PMID: 29085226 DOI: 10.3748/wjg.v23.i37.6833] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i37/6833.htm |
| Number | Citing Articles |
| 1 |
Jie Zhao, Xin Liu, Yao Chen, Lin-Shuang Zhang, Ya-Rong Zhang, Deng-Ren Ji, Shi-Meng Liu, Mo-Zhi Jia, Yong-Hong Zhu, Yong-Fen Qi, Feng-Min Lu, Yan-Rong Yu, De'Broski R. Herbert. STAT3 Promotes Schistosome-Induced Liver Injury by Inflammation, Oxidative Stress, Proliferation, and Apoptosis Signal Pathway. Infection and Immunity 2021; 89(3) doi: 10.1128/IAI.00309-20
|
| 2 |
Florence A. Servais, Mélanie Kirchmeyer, Matthias Hamdorf, Nadège W.E. Minoungou, Stefan Rose-John, Stephanie Kreis, Claude Haan, Iris Behrmann. Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3. Molecular Therapy - Nucleic Acids 2019; 16: 419 doi: 10.1016/j.omtn.2019.03.007
|
| 3 |
Albert Caballeria-Casals, Marc Micó-Carnero, Carlos Rojano-Alfonso, Cristina Maroto-Serrat, Araní Casillas-Ramírez, Ana I. Álvarez-Mercado, Jordi Gracia-Sancho, Carmen Peralta. Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?. Cells 2021; 10(6): 1421 doi: 10.3390/cells10061421
|
| 4 |
Muhammed Mehdi Üremiş, Nuray Üremiş, Yusuf Türköz. Cucurbitacin E shows synergistic effect with sorafenib by inducing apoptosis in hepatocellular carcinoma cells and regulates Jak/Stat3, ERK/MAPK, PI3K/Akt/mTOR signaling pathways. Steroids 2023; 198: 109261 doi: 10.1016/j.steroids.2023.109261
|
| 5 |
Wajahat Mehal. NASH and HCC Are Driven by Different Signaling Pathways with a Common Regulator. Cell Metabolism 2019; 29(1): 3 doi: 10.1016/j.cmet.2018.12.012
|
| 6 |
Yu Jiang, Qiu-Ju Han, Jian Zhang. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World Journal of Gastroenterology 2019; 25(25): 3151-3167 doi: 10.3748/wjg.v25.i25.3151
|
| 7 |
Lei Tang, Jin-Xia Liu, Zi-Juan Zhang, Chen-Zhou Xu, Xue-Ning Zhang, Wei-Rong Huang, Dan-Hua Zhou, Rong-Rong Wang, Xu-Dong Chen, Ming-Bing Xiao, Li-Shuai Qu, Cui-Hua Lu. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis. Pathology - Research and Practice 2019; 215(6): 152386 doi: 10.1016/j.prp.2019.03.015
|
| 8 |
Chin-Hsien Tsai, Yu-Ming Chuang, Xiaoyun Li, Yi-Ru Yu, Sheue-Fen Tzeng, Shao Thing Teoh, Katherine E. Lindblad, Mario Di Matteo, Wan-Chen Cheng, Pei-Chun Hsueh, Kung-Chi Kao, Hana Imrichova, Likun Duan, Hector Gallart-Ayala, Pei-Wen Hsiao, Massimiliano Mazzone, Julijana Ivanesevic, Xiaojing Liu, Karin E. de Visser, Amaia Lujambio, Sophia Y. Lunt, Susan M. Kaech, Ping-Chih Ho. Immunoediting instructs tumor metabolic reprogramming to support immune evasion. Cell Metabolism 2023; 35(1): 118 doi: 10.1016/j.cmet.2022.12.003
|
| 9 |
Eman H. Yousef, Nada F. Abo El-Magd, Amal M. El Gayar. Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7. Life Sciences 2023; 324: 121735 doi: 10.1016/j.lfs.2023.121735
|
| 10 |
Melanie J. Mittenbühler, Hans-Georg Sprenger, Sabine Gruber, Claudia M. Wunderlich, Lara Kern, Jens C. Brüning, F. Thomas Wunderlich. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma. Molecular Metabolism 2018; 17: 122 doi: 10.1016/j.molmet.2018.08.010
|
| 11 |
Rodrigo Carlessi, Julia Köhn-Gaone, John K. Olynyk, Janina E. E. Tirnitz-Parker. Hepatocellular Carcinoma. 2019; : 69 doi: 10.15586/hepatocellularcarcinoma.2019.ch4
|
| 12 |
Yuki Makino, Hayato Hikita, Seiya Kato, Masaya Sugiyama, Minoru Shigekawa, Tatsuya Sakamoto, Yoichi Sasaki, Kazuhiro Murai, Sadatsugu Sakane, Takahiro Kodama, Ryotaro Sakamori, Shogo Kobayashi, Hidetoshi Eguchi, Nobuyuki Takemura, Norihiro Kokudo, Hideki Yokoi, Masashi Mukoyama, Tomohide Tatsumi, Tetsuo Takehara. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(1): 99 doi: 10.1016/j.jcmgh.2022.09.006
|
| 13 |
Lorena Pantano, George Agyapong, Yang Shen, Zhu Zhuo, Francesc Fernandez-Albert, Werner Rust, Dagmar Knebel, Jon Hill, Carine M. Boustany-Kari, Julia F. Doerner, Jörg F. Rippmann, Raymond T. Chung, Shannan J. Ho Sui, Eric Simon, Kathleen E. Corey. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96966-5
|
| 14 |
Hye Lee, Jinhyeok Choi, Taekwon Son, Eun Lee, Jeong‑Gyun Kim, Soo Ryu, Danbi Lee, Myoung Jang, Eunsil Yu, Young‑Hwa Chung, Irwin Gelman, Kyu‑Won Kim. A‑kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide‑induced liver injury. Oncology Letters 2018; doi: 10.3892/ol.2018.9396
|